The global gene therapy market was valued at USD 3.61 billion in 2019 and is projected to reach USD 35.67 billion by 2027, growing at a robust compound annual growth rate (CAGR) of 33.6%. In 2019, the United States led the global landscape, accounting for 59.83% of the total market share.
The gene therapy market is rapidly evolving as a transformative area of modern medicine, offering the potential to treat, manage, or even cure genetic and acquired diseases at their source. By introducing, altering, or silencing genes within a patient’s cells, gene therapy provides targeted solutions for conditions such as cancer, rare genetic disorders, and neurodegenerative diseases. Advancements in vector technology, genome editing tools like CRISPR, and increasing regulatory support have significantly accelerated clinical developments. Growing investments, strategic partnerships, and rising demand for personalized medicine continue to drive the growth of the gene therapy market, positioning it as a major frontier in biotechnology and therapeutic innovation.
Tariff Impact Analysis for Gene Therapy Market: https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243
Market Segmentation:
By therapy type, the gene therapy market is segmented into ex vivo and in vivo approaches.
Based on vector type, segmentation includes viral vectors (such as lentivirus and AAV) and non-viral vectors.
According to application, the gene therapy market covers oncology, genetic disorders, cardiovascular diseases, neurological conditions, and ophthalmological indications.
End-user segments in the gene therapy market include hospitals, specialty clinics, academic research institutes, and contract research organizations (CROs).
Another segmentation layer comprises commercial and non-commercialized therapies in the gene therapy market pipeline.
List Of Key Companies Profiled in Gene Therapy Market: